Table 1. Frequency of ILN in liver metastases from colorectal cancer according to treatment.
No treatment, N=29 | CT only, N=31 | CT+Beva, N=31 | P-valuea | |
---|---|---|---|---|
Presence of ILN |
0 (0%) |
12 (39%) |
21 (68%) |
P<0.001 |
Lack of ILN | 29 (100%) | 19 (61%) | 10 (32%) |
Abbreviations: Beva=bevacizumab; CT=chemotherapy; ILN=infract-like necrosis.
χ2-test.